Bicistronic vectors are essential to achieve efficient expression of multiple genes in gene therapy protocols and biomedical applications. Internal ribosome entry site (IRES) elements have been utilized to initiate expression of an additional protein from a bicistronic vector. The IRES element commonly used in current bicistronic vectors originates from the encephalomyocarditis virus (EMCV). As IRES-mediated translation is dependent on availability of IRES trans-acting factors, which vary between cell types and species, adequate gene expression from the EMCV IRES element is not always achieved. To identify a novel IRES element that mediates gene expression consistently with a higher efficiency than the EMCV IRES, we tested 13 bicistronic reporter constructs containing different viral and cellular IRES elements. The in vitro screening in human and mouse fibroblast and hepatocarcinoma cells revealed that the vascular endothelial growth factor and type 1 collagen-inducible protein (VCIP) IRES was the only IRES element that directed translation more efficiently than the EMCV IRES in all cell lines. Furthermore, the VCIP IRES initiated greater reporter expression levels than the EMCV IRES in transfected mouse livers. These results suggest that VCIP-IRES containing vectors improve gene expression compared with those harboring an EMCV-IRES. This could increase the potential benefits of bicistronic vectors for experimental and therapeutic purposes.
INTRODUCTION
In eukaryotes, translation can be initiated by different mechanisms. Most of eukaryotic mRNAs are translated by a mechanism known as cap-dependent translation as a cap structure at the terminal base of the 5¢-untranslated region (5¢-UTR) is required. 1,2 Some cellular and viral mRNAs are translated through a different mechanism in which the ribosome is recruited by an RNA structure called internal ribosome entry site (IRES). [3] [4] [5] As IRES elements can promote internal initiation of translation without a cap structure, they have been used in bicistronic and polycistronic vectors for co-expression of proteins of interest. In these vectors, a viral promoter directs the synthesis of a single mRNA strand containing an IRES element between open reading frames. The first gene is translated by a cap-dependent, ribosome scanning, mechanism with its own 5¢-UTR, whereas translation of the subsequent gene is accomplished by the direct recruitment of ribosomes to the IRES in a cap-independent manner. Another approach to design vectors to express multiple proteins is the insertion of viral self-cleaving 2A peptides between the genes. 6, 7 With combined use of IRES elements and the 2A peptides in a single vector, polycistronic vectors have been successfully established. 8, 9 Because of their ability to produce multiple proteins in a single cell, bicistronic and polycistronic vectors have been widely used in the fields of gene therapy and biomedical research.
Translation initiation by IRES sequences was originally discovered in picornaviruses, 5 and several other viral and cellular mRNAs containing an IRES were subsequently discovered. [10] [11] [12] The primary sequences and secondary structures of IRES elements are diverse and similarities have not yet been found among cellular IRES elements or between different viral groups. IRES trans-acting factors, which interact with IRES elements to regulate translation efficiency by modulating ribosomal recruitment or by modifying IRES structures, also vary with different viral and cellular IRES elements. Because of these diversities, different IRES elements show distinct translation efficiencies depending on cell type and cellular conditions. Currently, the most commonly used IRES for pharmaceutical and biomedical application originates from encephalomyocarditis virus (EMCV). The complete EMCV sequence was reported in 1986 (ref. 13 ) and, shortly after, its 5¢-UTR was shown to initiate protein translation of the downstream gene by a cap-independent mechanism from a bicistronic reporter gene construct. 14 This discovery encouraged the development of the first commercial vector including the EMCV IRES element, pCITE1, by Novagen (Madison, WI, USA), and since then several vectors containing the EMCV IRES to promote expression of a second gene have been engineered. However, it has been reported that expression levels of target genes under control of the EMCV IRES commercially available are often insufficient [15] [16] [17] [18] and, therefore, may not be suitable to achieve therapeutic efficacy in gene therapy. To address this issue, several groups have sought to identify alternative cellular and viral IRES elements that initiate protein expression more efficiently than EMCV IRES. 15, [19] [20] [21] [22] [23] [24] [25] [26] Cellular IRES elements such as eukaryotic initiation factor 4G, 15 immunoglobulin heavy chain binding protein, 15 c-myc proto-oncogene, 15 vascular endothelial growth factor 15 and fibroblast growth factor-1 27 IRES have been reported to show higher efficiency than EMCV IRES. In this study, we searched to identify an IRES(s) with higher translation efficiency than the EMCV IRES both in vitro and in vivo. We constructed 13 different bicistronic reporter vectors containing different cellular and viral IRES, which were tested in vitro using cell lines of different origins, and in vivo using hydrodynamic gene delivery in mice.
RESULTS
Five viral and eight cellular IRES elements were used in this study: foot and mouth disease virus (FMDV), 28 hepatitis C virus (HCV), 28 EMCV, 29 poliovirus (PV), 29 human rhinovirus (HRV), 12 cold stress-induced mRNA (Rbm3), 30 human NF-kB repressing factor (NRF), 31 human apoptotic protease-activating factor-1 (Apaf-1), 32 immunoglobulin heavy chain binding protein (BIP), 33 vascular endothelial growth factor and type 1 collagen inducible protein (VCIP), 34 aquaporin 4 (AQP-4), 35 c-myc 33 and rat cationic aminoacid (arginine/lysine) transporter-1 (CAT-1). 36 Sequence information of the IRES elements is included in Supplementary Table S1 . The reporter constructs were prepared by inserting an IRES element into the bicistronic pRF vector (Supplementary Figure S1) . The pRF bicistronic constructs containing the human rhinovirus IRES and Rbm3 IRES were obtained from Dr A Willis and Dr VP Mauro, respectively. 12,30 IRES elements from EMCV, foot and mouth disease virus, hepatitis C virus, poliovirus, AQP-4 and NF-kB repressing factor were amplified from the original plasmid by PCR using specific primers (Supplementary Table S2 ). Apoptotic protease-activating factor-1, immunoglobulin heavy chain binding protein, c-myc and VCIP IRES fragments were digested from the original constructs and then subcloned into the pRF bicistronic construct. All the reporter constructs were confirmed by sequence analysis. In this system, Renilla luciferase activity represents cap-dependent translation, whereas firefly luciferase activity represents IRES-dependent translation.
We first conducted in vitro screening to identify IRES elements that can initiate higher protein expression than the EMCV IRES. Cell lines representing various cell types of human and mouse origins (murine fibroblast cell line (NIH 3T3), mouse embryonic fibroblasts (MEF), human hepatoma cell line (Huh 7) and human lung fibroblasts (MRC-5)) were transfected with a bicistronic pRF vector construct containing one of the 13 IRES elements or the empty control construct. These results confirmed those from a previous study showing that c-myc IRES initiated protein expression better than EMCV IRES in some cell types. 15 Importantly, VCIP IRES was the only IRES that showed consistently higher activity relative to EMCV IRES in all the cell lines investigated. The protein expression initiated by VCIP IRES was 48-fold higher in NIH 3T3, 61-fold higher in MEF, 538-fold higher in Huh 7 and 238-fold higher in MRC-5 compared with the EMCV IRES. The presence of an IRES in bicistronic vectors may interfere with cap-dependent translation of the upstream Renilla luciferase gene, which is an undesirable outcome for expression vectors. When we compared Renilla luciferase expression (Figures 1e-h) , none of the 13 IRES elements showed decreased levels compared with EMCV IRES, with the exception of the construct containing NF-kB repressing factor IRES element in NIH 3T3 cell line (Figure 1e ). These results show that there are IRES elements capable of mediating downstream gene expression significantly better than EMCV IRES without inhibiting cap-mediated expression of the upstream gene in cell culture systems.
We next investigated whether the IRES elements that initiated highly efficient protein expression in vitro would also exhibit higher efficiencies in mouse liver. Bicistronic constructs with EMCV, human rhinovirus, AQP-4, cationic amino-acid (arginine/lysine) transporter-1, c-myc or VCIP IRES, or a control construct were transfected into the liver of mice using hydrodynamic gene delivery. The protein expression levels of firefly and Renilla luciferase were standardized to the amount of bicistronic plasmid DNA taken up by the liver (Figures 2a and b) . We found that the expression of firefly luciferase was significantly higher (23-fold) in the livers of mice transfected with the VCIP IRES construct than those with the EMCV IRES construct (Po0.01) (Figure 2a) . In contrast, no significant differences in firefly activity were observed between the other IRES elements (human rhinovirus, AQP-4, cationic amino-acid (arginine/lysine) transporter-1 and c-myc) and EMCV IRES. Renilla luciferase expression was not significantly different among any of the constructs (Figure 2b) , suggesting that the presence of IRES in the bicistronic vector does not interfere with cap-dependent translation of the upstream gene in vivo. We also confirmed theses results by normalizing the luciferase activities in the livers of mice transfected with pRF, EMCV and VCIP constructs to the amount of bicistronic mRNA (Figures 2c and d) . Overall, these data show that VCIP IRES, consistent with in vitro results, has the ability to initiate IRES-mediated protein expression in vivo with a greater efficiency than EMCV IRES, which currently is commonly used in gene therapy and biomedical research.
The introduction of certain IRES sequences into expression vectors is known to initiate spurious mRNA splicing events. 37, 38 In addition, aberrant transcripts generated from a cryptic promoter present within the putative IRES have been reported 39, 40 and the presence of foreign IRES elements in mRNA may also affect the stability of the transcript. Therefore, it is possible that the observed changes in the expression levels of firefly and Renilla luciferase protein may be due to regulation at the transcriptional level and not at the translational level. To clarify this, the transcription and stability of bicistronic mRNAs were examined. We first conducted reverse transcription-PCR analysis for Renilla and firefly luciferase genes on RNA isolated from NIH 3T3 cells transfected with the various constructs (Figure 3a) . Both Renilla and firefly luciferase mRNAs were expressed to a similar level from all bicistronic constructs tested, indicating that the presence of these IRES sequences in the mRNA does not noticeably affect the stability of the transcript. Next, using quantitative RT-PCR we determined whether mRNA splicing or cryptic promoters are generated by the introduction of an IRES element (Figure 3b ). In the presence of splicing or a cryptic promoter, the ratio of the expression levels of Renilla and firefly luciferase mRNA would change. We found significant decreased levels of Renilla luciferase mRNA compared with those of firefly luciferase mRNA in AQP-4 construct, whereas we did not observe significant differences in the Renilla/firefly ratio in any of the other constructs compared to EMCV IRES construct. We further examined AQP-4, EMCV, VCIP and pRF transcripts by RT-PCR, and found that the AQP-4 construct, but not the other bicistronic constructs, expressed multiple transcripts, suggesting possible presence of splicing (Supplementary Figure S2) . Taken together, these results suggest that the introduction of the IRES elements examined in this study do not affect the stability of bicistronic mRNA and, with the exception of AQP-4 IRES, do not create alternative transcripts.
DISCUSSION
Bicistronic vectors containing EMCV IRES have been widely used for in vitro and in vivo applications such as co-expression of reporter genes or selective markers, generation of induced pluripotent stem cells in biomedical research as well as treatment of complex disorders in gene therapy protocols. 27, [41] [42] [43] [44] In this study, to identify novel IRES sequences that can improve expression vectors, we conducted in vitro and in vivo screening of 13 IRES elements from viral or cellular origin.
Importantly, we found that VCIP IRES was the only IRES to significantly increase translation initiation of the downstream gene compared with EMCV IRES in all the cell lines tested, as well as in mice. Furthermore, we confirmed the previous report that introduction of a VCIP IRES does not affect the stability of bicistronic mRNA, introduce a cryptic promoter, or result in alternative mRNA transcripts being produced. 34 VCIP, also known as phosphatidic acid phosphatase-2b, and human lipid phosphate phosphohydrolase-3, plays critical roles in many cellular functions. VCIP is ubiquitously expressed in tissues from mouse and human origins, [45] [46] [47] and is essential during mouse embryo development as VCIP knockout embryos die between embryonic days 7 and 9.5 (ref. 48) , VCIP has lipid phosphatase activity and converts phosphatidic acid into diacylglycerol, a second messenger implicated in lipid metabolism. VCIP is also known as a pro-angiogenic protein as addition of anti-VCIP antibody significantly blocked capillary morphogenesis of endothelial cells. 34, 49, 50 Because the efficiency of IRES-mediated translation is highly dependent on the cellular availability of IRES trans-acting factors, 44, 51 and considering the important biological roles of VCIP, it is likely that the expression levels of VCIP's IRES trans-acting factors are consistently high in a broad range of cell types. Interestingly, VCIP IRES activity increases by 20-fold under hypoxic stress compared with normal cell culture conditions. 34 As it is well documented that the microenvironment of solid tumors is usually hypoglycemic and hypoxic, 52, 53 this particular feature of VCIP IRES may be useful for cancer gene therapy protocols.
We found that some IRES elements show cell line-specific protein expression. For example, translation mediated by c-myc IRES was more efficient than EMCV IRES in Huh 7 and MRC-5 cell lines, whereas Rbm3 IRES-dependent translation was significantly different in MEF as well as in Huh 7 cells. These results are in concordance with Wong et al., 15 who showed higher gene expression mediated by c-myc IRES compared with EMCV IRES in KB-3-1 and N2a cells, but not in HEK293 cells. This observation warrants further study as this may enable tissue-specific expression of a gene, which may be important for gene therapy applications.
The objective of this study is to identify an IRES element(s) that initiates protein expression with higher efficiency than the EMCV IRES element, which is most commonly used in biomedical research and gene therapy application. It needs to be mentioned that the sequence of the EMCV IRES currently used in expression vectors have Efficient and consistent protein expression from VCIP IRES M Licursi et al been modified from that of the wild-type EMCV IRES. 20, 54 During the establishment of expression vectors with an EMCV IRES, the native EMCV IRES has been modified to create restriction enzyme sites to allow ligation of multiple reading frames in these vectors. The native EMCV AUG has also been removed in some of the commercial vectors. The modified EMCV IRES sequence has been shown by Bochkov and Palmenberg 54 to reduce protein expression by up to 10-fold compared with the native sequence. Blais et al. 34 showed that the VCIP IRES element spans 140-380 bp within the 568 bp length of the VCIP 5¢-UTR used in this study. However, deletion of the first 140 bp resulted in the abolishment of VCIP IRES activity, whereas translation initiation was partially inhibited in the absence of 380-568 bp region compared with the full-length 568-bp VCIP IRES element. These suggest that VCIP IRES activity depends on the optimal secondary structure affected by the upstream and downstream sequences, as well as the native VCIP AUG. Therefore, it is likely that the full-length 568-bp VCIP IRES element is required in expression and in gene therapy vectors to achieve the most efficient protein expression. In summary, expression vectors harboring a VCIP IRES consistently showed greater efficiencies of protein expression in both cell culture and in animal models. The introduction of the VCIP IRES into the bicistronic vector did not cause modification of the bicistronic transcript such as splicing, cryptic promoter generation or instability of the vector mRNA. These results warrant further studies to develop expression vectors containing VCIP IRES for improved biomedical research and gene therapy applications. (values relative to PRF) Figure 3 Absence of bicistronic mRNA modification in response to inclusion of IRES sequence. (a) RT-PCR on Renilla and firefly luciferase mRNA, as well as glyceraldehyde 3-phosphate dehydrogenase mRNA was performed on total RNA isolated from NIH 3T3 cells transfected for 24 h with bicistronic reporter constructs. Cells plated in 12-well plates were lysed in 0.4 ml TRIzol for cytoplasmic RNA isolation. To remove plasmid DNA, isolated RNA was treated with Turbo DNA-free DNase (Ambion) according to the manufacturer's instructions. For RT-PCR, RNA (0.5 mg) was reverse transcribed (RT) to cDNA from random hexamers using the first-strand cDNA synthesis kit from Amersham Biosciences, followed by PCR analysis using specific primers to each construct (Supplementary Table S2 ), including omission of reverse transcriptase RT(À), positive control (plasmid) and no template control (NTC). (b) RT-qPCR was performed to quantify Renilla and firefly luciferase mRNA. For analysis of mRNA transcribed from transfected plasmid, RNA was treated with Turbo DNA-free DNase (Ambion) and cDNA prepared as described above. qPCR was then performed in duplicate on the StepOnePlus (Applied Biosystems) using Power SYBR Green PCR Master Mix (Applied Biosystems). Cycling conditions were as follows: 95 1C for 10 min, 40 cycles at 95 1C for 15 s and 60 1C for 1 min, followed by meltcurve analysis. The Renilla luciferase/firefly luciferase ratio was calculated as 2 À[CT (Renilla) À CT (Firefly)] . Data are mean ± s.e. of five independent experiments. Statistical analyses were performed with one-way analysis of variance test and Dunnet's post-test using EMCV as the reference group. *Po0.01.
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